The largest database of trusted experimental protocols

9 protocols using ω conotoxin gvia

1

Modulating Spinal Cord Ca2+ Dynamics

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spontaneous Ca2+ activity in the developing spinal cord was modified using both pharmacological and genetic approaches. For pharmacological manipulation of spontaneous Ca2+ activity, agarose beads impregnated with 1 mM veratridine (voltage-gated Na+ channel agonist, Sigma) or a cocktail of voltage-gated Ca2+ and Na+ channel blockers (VGCblock; 200 nM calcicludine (Calbiochem), 10 μM ω-conotoxin–GVIA, 10 μM flunarizine, and 10 μg/ml tetrodotoxin (Sigma)) were implanted at stage 17-18. For genetic manipulation of spontaneous Ca2+ activity, rNav2aαβ (Nav2a, 100 pg rNav2aα and 500 pg rNav2aβ mRNA) was bilaterally injected at the two-cell stage. Embryos were grown at room temperature until stage 35–36 when samples were collected and processed for immunostaining with anti-HB9 (Developmental Studies Hybridoma Bank) as described above in Immunostaining. Immunoreactive cells were counted in at least 20 consecutive sections per larva, and from at least 4 larvae per treatment.
+ Open protocol
+ Expand
2

Preparation of Calcium Channel Blockers

Check if the same lab product or an alternative is used in the 5 most similar protocols
ω-conotoxin GVIA (C9915) was purchased from Sigma-Aldrich and dissolved in phosphate buffered saline (PBS; pH 7.4). Nifedipine (481981) was purchased from Calbiochem and was dissolved in DMSO.
+ Open protocol
+ Expand
3

Neuropharmacological Compound Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cadmium chloride, ω-conotoxin GVIA (CTX), ω-agatoxin IVA (ATX), tetrodotoxin (TTX), Bay K 8644, nifedipine, quinpirole, sulpiride, CP-93,129, (2R)-amino-5-phosphonovaleric acid (APV), 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione (NBXQ), picrotoxin and citalopram were obtained from Sigma-Aldrich. Oxotremorine-m (OXO-M), dihydro-β-erythroidine (DHβE), and scopolamine were obtained from Tocris Cookson. Drugs were dissolved as stock solutions in water or DMSO and aliquoted and frozen at −20°C before use. Each of the drugs was diluted in aCSF immediately before each experiment. When used, the final concentration of DMSO external solution was always <0.05%.
+ Open protocol
+ Expand
4

Voltage-Gated Channel Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The treatment began 30 min prior to electrical stimulation, and continued throughout the stimulation. Each drug was added to both stimulated and unstimulated cultures. Tetrodotoxin (TTX; 3 mM stock in citrate buffer, pH=4.8; Tocris Bioscience, Ellisville, MO), ω-conotoxin GVIA (50 μM stock in PBS; Sigma), and nimodipine (10 mM stock in ethanol; Sigma), were used at final concentrations of 1.5 μM, 1 μM, and 2 μM, respectively.
+ Open protocol
+ Expand
5

Modulating Spinal Cord Ca2+ Dynamics

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spontaneous Ca2+ activity in the developing spinal cord was modified using both pharmacological and genetic approaches. For pharmacological manipulation of spontaneous Ca2+ activity, agarose beads impregnated with 1 mM veratridine (voltage-gated Na+ channel agonist, Sigma) or a cocktail of voltage-gated Ca2+ and Na+ channel blockers (VGCblock; 200 nM calcicludine (Calbiochem), 10 μM ω-conotoxin–GVIA, 10 μM flunarizine, and 10 μg/ml tetrodotoxin (Sigma)) were implanted at stage 17-18. For genetic manipulation of spontaneous Ca2+ activity, rNav2aαβ (Nav2a, 100 pg rNav2aα and 500 pg rNav2aβ mRNA) was bilaterally injected at the two-cell stage. Embryos were grown at room temperature until stage 35–36 when samples were collected and processed for immunostaining with anti-HB9 (Developmental Studies Hybridoma Bank) as described above in Immunostaining. Immunoreactive cells were counted in at least 20 consecutive sections per larva, and from at least 4 larvae per treatment.
+ Open protocol
+ Expand
6

Pharmacological Agents for Neurophysiology

Check if the same lab product or an alternative is used in the 5 most similar protocols
ω-conotoxin GVIA (CTX), ω-agatoxin IVA (ATX), nifedipine, quinpirole and sulpiride, were obtained from Sigma-Aldrich. (1S, 2S)-2-[2-[[3-(1H-Benzimidazol-2-yl) propyl] methylamino]ethyl]-6-fluoro- 1, 2, 3, 4-tetrahydro-1-(1-methylethyl)-2-naphthalenyl cyclopropanecarboxylate dihydrochloride (NNC 50-0396), Cyclopiazonic acid (CPA) and dihydro-β-erythroidine (DHβE) were obtained from Tocris Cookson. Drugs were dissolved as stock solutions in water or DMSO and aliquoted and frozen at −20 °C before use. Each of the drugs was diluted in aCSF immediately before each experiment. When used, the final concentration of DMSO external solution was always <0.05%.
+ Open protocol
+ Expand
7

Intrathecal Injection of Neurotoxins in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
ω-conotoxin GVIA (Sigma-Aldrich U.S.A.), ω-conotoxin MVIIC (Alomone Labs, Jerusalem, Israel), and ω-agatoxin IVA (Sigma-Aldrich U.S.A.) were dissolved in sterile saline. Nifedipine (Sigma-Aldrich U.S.A.) was first dissolved in a stock solution of 10 mM with 50% DMSO in saline. This was further diluted to the appropriate testing dilutions with saline to a final DMSO concentration <0.0001%, which did not affect the behavioral sensitivity of animals (data not shown). These drug solutions were injected intrathecally (5 µL/mouse) between lumbar regions L4–L5 via a 30-gauge, 1/2-inch needle attached to a microinjector (Tritech Research Inc, Los Angeles, CA) (Inoue et al., 2004 (link)). In the case that mice were used for repetitive injections, a drug-free period of at least 48 hours after the last drug injection was introduced. Molarity of injected drugs was calculated based on estimated 40 µL mouse cerebrospinal fluid (Johanson et al., 2008 (link)).
+ Open protocol
+ Expand
8

Pharmacological Toolkit for Neuroscience Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX), D-(−)-2-Amino-5-phosphonopentanoic acid (AP5), strychnine, picrotoxin, tetraethylammonium (TEA), 4-aminopyradine (4-AP), tetrodotoxin (TTX), nifedipine, ω-conotoxin GVIA, ω-conotoxin MVIIC, lidocaine N-ethyl bromide (QX-314), was obtained from Sigma Aldrich (St. Louis, MO, USA). TTX, nifedipine, ω-conotoxin GVIA, ω-conotoxin MVIIC, QX-314, and nickel were prepared as 1000X stock solutions. nifedipine, and QX-314 were prepared in DMSO. TTX was prepared in water. Stock solutions of ω-conotoxin GVIA and ω-conotoxin MVIIC were prepared in deoxygenated solution containing 0.1% BSA, 100 mM NaCl, 10 mM Trizma, and 1 mM EDTA, pH 7.5. Drugs were then diluted to working concentrations directly preceding experiments. TTA-P2 was obtained from Alomone Labs.
+ Open protocol
+ Expand
9

Preparation of Neuroscience Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
TTX, 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(f)-quinox aline (NBQX), DL-2-amino-5-phosphonopentanoic acid (AP5), ω-Conotoxin GVIA, ω-agatoxin IVA and LY379268 were prepared in distilled H 2 O. Baclofen was prepared in 0.5% acetic acid. CGP55845, LY341495, nifedipine and ryanodine were prepared in DMSO. All drugs were diluted to their final concentrations in aCSF (final DMSO concentrations were ࣘ0.1%). TTX and AP5 were purchased from Abcam (Cambridge, MA, USA). ω-Conotoxin GVIA and ω-agatoxin IVA were purchased from Sigma-Aldrich (St Louis, MO, USA). All other drugs were purchased from Tocris Bioscience (Ellisville, MO, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!